Cannabis has been a plant used by humans for thousands of years, both for medicinal and recreational purposes. However, it was in the mid-20th century that the molecule responsible for the plant's psychoactive effects was discovered: delta-9-tetrahydrocannabinol (THC).
This finding was the work of Israeli chemist Raphael Mechoulamwho devoted much of his career to the study of cannabis and its components. In this article, we will explore the life and work of Mechoulam, known as the "father" of THC.
Raphael Mechoulam's work has been fundamental to the field of cannabis research. His discovery of THC and its effects on the human body has led to new research into how cannabis can be used to treat diseases such as epilepsy, multiple sclerosis and Parkinson's disease.
The life of Raphael Mechoulam
Raphael Mechoulam was born in Bulgaria in 1930 and emigrated to Israel with his family in 1949. He studied chemistry at the Hebrew University of Jerusalem, where he earned his PhD in 1958. It was during his time at the university that he began his interest in cannabis research and its components.
The discovery of THC
In 1963, Mechoulam and his team succeeded in isolating THC for the first time. From there, they began to study its effects on the brain and the human body. They discovered that THC binds to specific receptors in the brain, which causes the characteristic psychoactive effects of cannabis.
Subsequent research
Throughout his career, Mechoulam continued to research cannabis and its components. He discovered other important cannabinoids, such as cannabidiol (CBD), which has no psychoactive effects but may have medicinal properties.
In the 1980s, Mechoulam and his team discovered the endocannabinoid system, a neurotransmitter system that interacts with cannabinoids in the human body. This research has led to new investigations into how cannabis can be used to treat a variety of medical conditions.
The legacy of Raphael Mechoulam
Raphael Mechoulam's work has been fundamental to the field of cannabis research. His discovery of THC and its effects on the human body has led to new research into how cannabis can be used to treat diseases such as epilepsy, multiple sclerosis and Parkinson's disease.
In addition, his work has led to a better understanding of the endocannabinoid system and how cannabinoids interact with the human body. This has opened the door to new research on how cannabinoids can be used to treat a variety of medical conditions.
In short, Raphael Mechoulam was an Israeli chemist who devoted much of his career to the study of cannabis and its components. His discovery of THC and his work on the endocannabinoid system have been fundamental to the field of cannabis research. His legacy will continue to influence cannabis research in the future.
EN 
ES 
DE 
IT 
FR 